By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Bavarian Nordic A/S 

Vesterbrogade 149

Copenhagen    DK-1620  Denmark
Phone: 45-3326-8383 Fax: 45-3326-8380


SEARCH JOBS


Industry
Biotechnology

Segment
Vaccines





Company News
Bavarian Nordic (BAVA.CO) Announces Updated Overall Survival Data From Combination Immunotherapy Data Of PROSTVAC Plus Ipilimumab At The 2015 Genitourinary Cancers Symposium 2/24/2015 10:09:16 AM
Bavarian Nordic (BAVA.CO) Announces Initiation Of Phase 1 Clinical Trial For The Ebola Vaccine Regimen Of MVA-BN® Filo And Janssen's AdVac® technology 1/6/2015 8:53:04 AM
Bavarian Nordic (BAVA.CO) Reaches Enrollment Target In The Pivotal Phase 3 Study Of PROSTVAC® In Prostate Cancer 12/10/2014 8:33:53 AM
Ebola Clinical Trials: Big Name Players In The Ebola Race 10/20/2014 3:28:01 AM
Bavarian Nordic (BAVA.CO) Accelerates Ebola Vaccine Development Programs In Collaboration With The NIH 9/4/2014 8:58:11 AM
Johnson & Johnson (JNJ) Jumps Into The Ebola Race With Collaboration Of Crucell (JNJ) And Bavarian Nordic (BAVA.CO); Human Trials To Start In Early 2015 9/4/2014 6:06:51 AM
Bavarian Nordic (BAVA.CO) Announces First Half 2014 Results 8/28/2014 8:41:15 AM
Bavarian Nordic (BAVA.CO) Receives Order From The Canadian Government To Supply IMVAMUNE® Smallpox Vaccine 8/26/2014 7:45:38 AM
Bavarian Nordic (BAVA.CO) Is The Sole Bidder For Canadian Smallpox Vaccine Supply 8/6/2014 6:28:33 AM
Bavarian Nordic (BAVA.CO) Announces First Patient Treated In A Phase 1 Study Of MVA-BN® Brachyury In Advanced Cancer 7/24/2014 9:13:08 AM
12345678910...
//-->